Status:

UNKNOWN

The Effect of Acupressure and Halogen Light Stimulation on Nonstress Testing and Pregnant Anxiety

Lead Sponsor:

Ondokuz Mayıs University

Collaborating Sponsors:

Aydin Adnan Menderes University

Conditions:

Acupressure

Eligibility:

FEMALE

18-35 years

Phase:

NA

Brief Summary

Fetal death accounts for approximately half of perinatal death. Fetal health should be evaluated in order to identify fetuses at risk of intrauterine death and to prevent perinatal morbidity and morta...

Detailed Description

H01: There was no difference between the nonstress test results of pregnant women who received acupressure and control group pregnant women. H02: There was no difference between the anxiety levels of...

Eligibility Criteria

Inclusion

  • Those between the ages of 18-35,
  • Gestational week of 34 and above,
  • Single and live pregnancy,
  • Number of births ≤3
  • Having had Nonstress test at least once before,
  • Having regular antenatal follow-up,
  • Able to speak and understand Turkish,
  • Pregnant women with at least primary school graduates will be included in the study.
  • Eating at least two hours before the nonstress test,
  • Not using cigarettes, alcohol or drugs at least two hours before the Nonstress test,
  • Not doing vigorous activity at least two hours before the Nonstress test,
  • Urinating just before the Nonstress test,
  • Basal heart rate is 110-160 beats per minute.

Exclusion

  • Having more than one pregnancy loss,
  • Uterine contraction as a result of Nonstress test,
  • In any situation that develops acutely during the Nonstress test,
  • Those who could not complete the Nonstress test for any reason,
  • Psychologically diagnosed (such as depression, schizophrenia)
  • Any chronic disease (such as diabetes, hypertension, heart failure)
  • Pregnancy complications (such as preeclampsia, gestational diabetes, Rh incompatibility)
  • Pregnant with a history of infertility and assisted reproductive techniques,
  • A problem defined in the fetus (anomaly, intrauterine growth retardation and cardiovascular disease),
  • Pre-pregnancy body mass index calculated as 30 and above,
  • Pregnant women who give false or incomplete information will not be included in the study.

Key Trial Info

Start Date :

June 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 15 2022

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT05420883

Start Date

June 15 2022

End Date

December 15 2022

Last Update

June 15 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.